Long-term clinical value and outcome of riociguat in chronic thromboembolic pulmonary hypertension

BACKGROUND: To improve clinical outcome, patients with inoperable and residual chronic thromboembolic pulmonary hypertension (CTEPH) can be treated with riociguat. The aim of this study is to explore long-term outcomes and to compare our ‘real world’ data with previous research. METHODS: We included...

Descripción completa

Detalles Bibliográficos
Autores principales: van Thor, M.C.J., ten Klooster, L., Snijder, R.J., Post, M.C., Mager, J.J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396196/
https://www.ncbi.nlm.nih.gov/pubmed/30859124
http://dx.doi.org/10.1016/j.ijcha.2019.02.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396196/
https://www.ncbi.nlm.nih.gov/pubmed/30859124
http://dx.doi.org/10.1016/j.ijcha.2019.02.004

Ejemplares similares